Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Angiogenesis and retinal diseases].

Francisco Max Damico1

  • 1Universidade de São Paulo, São Paulo, SP, Brasil. fmdamico@uol.com.br

Arquivos Brasileiros De Oftalmologia
|September 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coronary artery and retinal vascularization by optical coherence tomography angiography: are eyes the window to the heart?

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2025
Same author

Lasting effects of prenatal exposure to Cannabis in the retina of the offspring: an experimental study in mice.

International journal of retina and vitreous·2021
Same author

Correlations Between Dark-Adapted Rod Threshold Elevations and ERG Response Deficits in Duchenne Muscular Dystrophy.

Investigative ophthalmology & visual science·2021
Same author

Three-Year Clinical Follow-Up of Children Intrauterine Exposed to Zika Virus.

Viruses·2021
Same author

Longitudinal visual acuity development in ZIKV-exposed children.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2020
Same author

Effects of <i>cannabis</i> and its components on the retina: a systematic review.

Cutaneous and ocular toxicology·2019
Same journal

Intravitreal dexamethasone sodium phosphate challenge to predict implant response in refractory diabetic macular edema: a pilot study.

Arquivos brasileiros de oftalmologia·2026
Same journal

Presumed ocular histoplasmosis syndrome phenocopy in Brazil.

Arquivos brasileiros de oftalmologia·2026
Same journal

Eyebrow and eyelid position in anophthalmic sockets reconstructed with conical or spherical implants: a quantitative analysis.

Arquivos brasileiros de oftalmologia·2026
Same journal

Corneal sensitivity recovery after phacoemulsification: quantitative esthesiometric analysis.

Arquivos brasileiros de oftalmologia·2026
Same journal

Musculoskeletal disorders in ophthalmologists and ophthalmology residents in Brazil.

Arquivos brasileiros de oftalmologia·2026
Same journal

Reliability of a Scheimpflug-based tomographer compared with a Placido-based topographer and specular microscopy in healthy eyes.

Arquivos brasileiros de oftalmologia·2026
See all related articles

Vascular endothelial growth factor (VEGF) drives new blood vessel growth in the eye, causing vision loss in diseases like macular degeneration. Anti-VEGF therapies offer new hope for treating these conditions.

Area of Science:

  • Ophthalmology and Molecular Biology
  • Study of angiogenesis and its role in ocular diseases

Context:

  • Angiogenesis, the growth of new blood vessels, is critical in both normal physiology and disease.
  • Proliferative retinal diseases, including age-related macular degeneration and proliferative diabetic retinopathy, lead to vision loss due to increased vascular permeability and choroidal neovascularization.
  • Vascular Endothelial Growth Factor (VEGF) is a key regulator, predominantly VEGF165 in the human eye, produced by retinal pigment epithelium (RPE) cells and upregulated by hypoxia.

Purpose:

  • To explore the role of angiogenesis, particularly VEGF, in pathological ocular neovascularization.
  • To identify key factors involved in the balance of pro- and antiangiogenic processes in the eye.
  • To highlight the development of novel therapeutic agents targeting angiogenesis for vision-threatening conditions.

Related Experiment Videos

Summary:

  • VEGF is a potent mitogen for endothelial cells, increasing vascular permeability, inhibiting apoptosis, and attracting precursor cells, making it central to pathological ocular neovascularization.
  • Other factors like basic fibroblast growth factor (bFGF), angiopoietins, pigment epithelium-derived factor (PEDF), and adhesion molecules also modulate the angiogenic balance.
  • Understanding these mechanisms has led to the development of anti-VEGF antibody therapies for intravitreal injection.

Impact:

  • Novel anti-VEGF therapies represent a significant advancement in treating the leading causes of irreversible blindness in individuals over 65.
  • These therapeutic agents hold promise for managing conditions characterized by pathological ocular angiogenesis.
  • Further research into angiogenesis regulators may yield additional innovative treatments for retinal diseases.